Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

KRT8 antibody

This anti-KRT8 antibody is a Mouse Monoclonal antibody detecting KRT8 in IF, FACS and IHC (f). Suitable for Human, Rabbit and Monkey.
Catalog No. ABIN6179123

Quick Overview for KRT8 antibody (ABIN6179123)

Target

See all KRT8 Antibodies
KRT8 (Keratin 8 (KRT8))

Reactivity

  • 314
  • 89
  • 78
  • 66
  • 65
  • 63
  • 62
  • 16
  • 13
  • 10
  • 8
  • 5
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
Human, Rabbit, Monkey

Host

  • 168
  • 163
  • 3
Mouse

Clonality

  • 184
  • 147
  • 1
Monoclonal

Conjugate

  • 172
  • 27
  • 17
  • 12
  • 9
  • 8
  • 8
  • 8
  • 8
  • 8
  • 8
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This KRT8 antibody is un-conjugated

Application

  • 240
  • 176
  • 123
  • 88
  • 71
  • 49
  • 48
  • 42
  • 41
  • 40
  • 37
  • 28
  • 22
  • 5
  • 5
  • 4
  • 4
  • 2
  • 2
  • 2
  • 1
  • 1
Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

KRT8-899
  • Purpose

    Mouse Monoclonal anti-Cytokeratin 8 (KRT8/899), Purified, BSA-free

    Characteristics

    Cytokeratin 8 (CK8) belongs to the type II (or B or basic) subfamily of high molecular weight cytokeratins and exists in combination with cytokeratin 18 (CK18). CK8 is primarily found in the non-squamous epithelia and is present in majority of adenocarcinomas and ductal carcinomas. It is absent in squamous cell carcinomas. Hepatocellular carcinomas are defined by the use of antibodies that recognize only cytokeratin 8 and 18. CK8 exists on several types of normal and neoplastic epithelia, including many ductal and glandular epithelia such as colon, stomach, small intestine, trachea, and esophagus as well as in transitional epithelium. Anti-CK8 does not react with skeletal muscle or nerve cells. Epithelioid sarcoma, chordoma, and adamantinoma show strong positivity corresponding to that of simple epithelia (with antibodies against CK8, CK18 and CK19). Reportedly, anti-CK8 is useful for the differentiation of lobular (?ring-like, perinuclear?) from ductal (?peripheral-predominant?) carcinoma of the breast. Primary antibodies are available purified, or with a selection of fluorescent CF® dyes and other labels. CF® dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Purification

    Purified

    Immunogen

    Recombinant human KRT8 protein

    Isotype

    IgM kappa
  • Application Notes

    Immunohistology formalin-fixed 0.5-1.0 μg/mL
    • Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer,  pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes
    • Flow Cytometry 0.5-1 μg/million cells/0.1 mL
    • Immunofluorescence 1-2 μg/mL
    • Optimal dilution for a specific application should be determined by user

    Comment

    MCF-7 or A431 cells. Skin, Colon, lung or breast carcinoma

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL

    Buffer

    PBS (no BSA, no azide)

    Preservative

    Azide free
  • Target

    KRT8 (Keratin 8 (KRT8))

    Alternative Name

    Cytokeratin 8

    Background

    CARD2, CK8, CYK8, CYKER, Cytokeratin Endo A, DreK8, EndoA, K2C8, K8, Keratin 8, Krt 2.8, KRT8, Type-II Keratin Kb8

    Molecular Weight

    52.5 kDa

    Gene ID

    3856

    UniProt

    P05787
You are here:
Chat with us!